This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

9th U.S. Circuit Court of Appeals

Sep. 30, 2024

FDA wins again: Can regulate stem cell treatments, 9th Circuit rules

The U.S. Food and Drug Administration has been going after stem cell treatment centers across the country, saying the procedure is marketed as a "cure-all."

9th Circuit Judge Michelle T. Friedland

In a victory for the U.S. Food and Drug Administration, a 9th U.S. Circuit Court of Appeals panel ruled Friday that the agency can regulate stem cell treatments by two Southern California centers as drugs under federal law.

The decision is a major victory for government regulators in their legal showdowns with medical clinics across the country that offer treatments using patients' own stem cells. An 11th U.S. Circuit Court of Appeals panel ruled in June 2021 for the FDA agai...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Sign up for Daily Journal emails